ONS 2021
![]() | Case Studies in Multiple Myeloma Care for Challenging Times – Part 1: Newly Diagnosed Multiple Myeloma, Including Treatment Disparities CNE Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN; and Amy E. Pierre, RN, MSN, ANP-BC | |
Release Date: April 09, 2021 Expiration Date: April 09, 2022 | ||
This activity on multiple myeloma care for challenging times will include discussion of treatment for newly diagnosed MM, including common regimens; treatment disparities and best practices; and survivorship care plans and practical tools for long-term management and care. Through the case of Bianca - an African American patient with newly diagnosed MM, our faculty will focus on symptom management, infection control, and nursing implications. Please remember to complete part 2 and 3 to receive a total of 1.5 CNE credits (3 sessions at 0.5 CNE). Free downloadable tools and resources are provided after completing the post-test and activity evaluation survey. | ||
![]() | Case Studies in Multiple Myeloma Care for Challenging Times – Part 2: Relapsed Multiple Myeloma CNE Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN; and Donna D. Catamero, ANP-BC, OCN, CCRC | |
Release Date: April 09, 2021 Expiration Date: April 09, 2022 | ||
This activity on multiple myeloma care for challenging times will include common treatment regimens in early relapsed MM; clinical trials including phases, myths, and how to find them; and nursing management, including symptom management. Through the cases of Joshua - a standard-risk patient experiencing a slow biochemical progression, and Kristen - a high-risk patient experiencing a symptomatic relapse, our faculty will focus on symptom management, infection control, and nursing implications. Please remember to complete part 1 and 3 to receive a total of 1.5 CNE credits (3 sessions at 0.5 CNE). Free downloadable tools and resources are provided after completing the post-test and activity evaluation survey. | ||
![]() | Case Studies in Multiple Myeloma Care for Challenging Times – Part 3: Heavily Pretreated Multiple Myeloma and Drugs in Development CNE Beth Faiman, PhD, RN, MSN, APRN-BC, AOCN®, FAAN; and Charise Gleason, MSN, NP-C, AOCNP® | |
Release Date: April 09, 2021 Expiration Date: April 09, 2022 | ||
This activity on multiple myeloma care for challenging times will include common treatment regimens in heavily pretreated MM; nursing management, including symptom management; and drugs in development. Through the cases of Judy – a standard-risk multiply relapsed patient experiencing biochemical progression, Ted – a high-risk multiply relapsed patient with symptomatic progression, and
Antonio – a standard-risk multiply relapsed patient with symptomatic progression, our faculty will focus on symptom management, infection control, and nursing implications. Please remember to complete part 1 and 2 to receive a total of 1.5 CNE credits (3 sessions at 0.5 CNE). Free downloadable tools and resources are provided after completing the post-test and activity evaluation survey.
| ||